Filing Flows › Comparisons › CGON vs DBVT
CG Oncology vs DBV Technologies S.A.: CGON and DBVT compared
CG Oncology is the larger company: $1.6M of revenue in its latest quarter (Q3 2026) against $1.6M for DBV Technologies S.A. (Q3 2026). CG Oncology is growing faster (-4% against -43% a year earlier).
Where the money goes: CGON and DBVT
CG Oncology (CGON) · Q3 2026
CG Oncology, Q3 2026: revenue $1.6M (-4% year over year), net loss $56.9M, operating cash flow −$47.7M. The chart follows the revenue to costs, profit and cash.
DBV Technologies S.A. (DBVT) · Q3 2026
DBV Technologies S.A., Q3 2026: revenue $1.6M (-43% year over year), net loss $64.5M, operating cash flow −$51.5M. The chart follows the revenue to costs, profit and cash.
| CG Oncology (CGON) | DBV Technologies S.A. (DBVT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.6M | $1.6M |
| Revenue growth, Y/Y | -4% | -43% |
| Operating margin | n/m | n/m |
| Net earnings | −$56.9M | −$64.5M |
| Operating cash flow | −$47.7M | −$51.5M |
Questions
Which is bigger, CG Oncology or DBV Technologies S.A.?
CG Oncology is the larger company: $1.6M of revenue in its latest quarter (Q3 2026) against $1.6M for DBV Technologies S.A. (Q3 2026).
Is CG Oncology or DBV Technologies S.A. growing faster?
CG Oncology is growing faster (-4% against -43% a year earlier).
More: CG Oncology earnings · how CG Oncology makes money · DBV Technologies S.A. earnings · how DBV Technologies S.A. makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Oct 28, 2026). Fiscal quarters can end on different dates. Not investment advice.